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Aim: The contribution of insulin resistance (IR) and glucose tolerance to the maintenance of blood glucose
levels in non diabetic pregnant Wistar rats (PWR) was investigated.
Main methods: PWR were submitted to conventional insulin tolerance test (ITT) and glucose tolerance test
(GTT) using blood sample collected 0, 10 and 60 min after intraperitoneal insulin (1 U/kg) or oral (gavage)
glucose (1 g/kg) administration. Moreover, ITT, GTT and the kinetics of glucose concentration changes in
the fed and fasted states were evaluated with a real-time continuous glucose monitoring system (RT-
CGMS) technique. Furthermore, the contribution of the liver glucose production was investigated.
Key ﬁndings: Conventional ITT and GTT at 0, 7, 14 and 20 days of pregnancy revealed increased IR and glucose
tolerance after 20 days of pregnancy. Thus, this period of pregnancy was used to investigate the kinetics of
glucose changes with the RT-CGMS technique. PWR (day 20) exhibited a lower (pb0.05) glucose concentra-
tion in the fed state. In addition, we observed IR and increased glucose tolerance in the fed state (PWR-day 20
vs. day 0). Furthermore, our data from glycogenolysis and gluconeogenesis suggested that the liver glucose
production did not contribute to these changes in insulin sensitivity and/or glucose tolerance during late
pregnancy.
Signiﬁcance: In contrast to the general view that IR is a pathological process associated with gestational dia-
betes, a certain degree of IR may represent an important physiological mechanism for blood glucose mainte-
nance during fasting.© 2012 Elsevier Inc. Open access under the Elsevier OA license.Introduction
During early pregnancy there is an anabolic state that is associated
with hyperphagia and body fat accumulation (Herrera, 2002). In con-
trast, during late pregnancy there is a catabolic state associated with
insulin resistance where not only glucose but also free fatty acids
and ketone bodies can serve as important sources of energetic sub-
strates during a fasting state (Herrera et al., 1994; Herrera, 2000).
During pregnancy, there are two main metabolic concerns. First,
there is possibility of gestational diabetes (ADA, 2011) where the
levels of insulin secretion cannot overcome the insulin resistance
that occurs in late pregnancy. Second, there is an increased predispo-
sition to hypoglycemia which occurs in not only humans (Vadakekut
et al., 2011) but also mice (Reddi et al., 1976), ewes (Schlumbohm
and Harmeyer, 2008), bitches (Johnson, 2008) and rats (Leturque et
al., 1989).vier OA license.Thus, the following two questions can be raised: 1. how can there
be a simultaneous increase in insulin resistance and a predisposition
to fasting hypoglycemic responses during late pregnancy? 2. Al-
though glucose tolerance is decreased during gestational diabetes,
what occurs with glucose tolerance during normal pregnancy consid-
ering the intense glucose utilization by the fetus, which can be 50% of
the maternal glucose utilization rate in the basal state (Herrera et al.,
1994)?
These questions are especially relevant when considering that ma-
ternal hypoglycemia has the potential to adversely affect the develop-
ing fetus (Kawaguchi et al., 1994; Reece et al., 1994; Johnson, 2008).
Moreover, because traditional methods of blood collection provide
little information about dynamic glucose levels, a real time continu-
ous glucose monitoring system (RT-CGMS) technique was employed
in this study. The RT-CGMS technique provides more detailed data re-
garding glucose changes because it is capable of measuring the glu-
cose concentration every 5 min, which results in 288 measurements
per day (Bode et al., 2004).
Therefore, in this study, we focused on the kinetics of glucose
changes, the participation of insulin resistance, glucose tolerance
832 M.A. Carrara et al. / Life Sciences 90 (2012) 831–837and liver glucose production with respect to the maintenance of
blood glucose concentrations during fed and fasted states in pregnant
Wistar rats.
Materials and methods
Materials
The glucose sensor device was obtained from Medtronic® (São
Saulo, SP, Brazil). Glucose was purchased from Sigma-Aldrich Chemi-
cal Company (St. Louis, USA). Regular insulin (Humulin®) was
obtained from Lilly (São Saulo, SP, Brazil). L-Alanine and L-glutamine
were obtained from ICN Biochemical's (Costa Mesa, CA, USA).
Animals and treatment
A total of 218 female Wistar rats after 0, 7, 14 or 20 days of preg-
nancy were used in this investigation. The rats were maintained at a
constant temperature (23 °C) and under an automatically controlled
photoperiod (12 h light/12 h dark). The protocol for these experi-
ments was approved by the Ethical Committee (058/2008) and com-
plied with the international law for the protection of the animals.
Conventional insulin tolerance test (ITT)
After 0 (NPWR) 7, 14 or 20 days of pregnancy the rats were food
deprived (8:00 p.m.–8:00 a.m.). At this time point the rats received
an intraperitoneal injection of regular insulin (1 U/kg) and were
killed by decapitation 0, 10 and 60 min after insulin administration.
The blood was collected and the glucose levels were measuredFig. 1. Glycemic measurements 0, 10 and 60 min after an intraperitoneal injection of insulin
(14 days) and (D) pregnant rats (20 days). (a) pb0.05— 0 min vs. 10 min; (b) pb0.05— 10 m
of 7–9 animals per group.using a traditional clinical laboratory method (glucose oxidase)
(Bergmeyer and Bernt, 1974).
The female rats were considered hypoglycemic when glucose
levels decreased to values below 40 mg/dL.Conventional glucose tolerance test (GTT)
After 0 (NPWR) 7, 14 or 20 days of pregnancy the rats were food
deprived (8:00 p.m.–8:00 a.m.). At this time, the rats received oral
(gavage) glucose (1 g/kg) and were killed by decapitation 0, 10 and
60 min after glucose administration. The blood was collected, and
the blood glucose levels were measured using a conventional colori-
metric laboratory method to measure glucose (Bergmeyer and
Bernt, 1974).Real-time continuous glucose monitoring System (RT-CGMS) technique
The kinetics of interstitial glucose changes were determined using
the RT-CGMS technique. The RT-CGMS device is composed of a glu-
cose sensor which is a membrane-covered electrode that detects glu-
cose levels in the interstitial ﬂuid and sends this information to the
transmitter, a transmitter which sends the data to the monitor
using high frequency radio waves and a monitor which provides
readings in real time (Medtronic Guardian® Real-Time CGMS). The
RT-CGMs system evaluates glucose levels every 10 s, and the results
obtained each 5 min represent the average sum of 30 glucose concen-
tration measurements. The glucose levels (about 280 values per day)
were stored in the monitor. The system measured glucose concentra-
tion in a range of 40–400 mg/dL.(1 U/kg). (A) Non-pregnant rats (0 day); (B) pregnant rats (7 days); (C) pregnant rats
in vs. 60 min; (c) pb0.05— 0 min vs. 60 min. The data are reported as the mean±SEM
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thetized with an intraperitoneal injection of sodium thiopental
(45 mg/kg). After a suitable level of anesthesia was achieved, the
area of skin on the back was shaved, and the sensor was manually
inserted in the interscapular region (subcutaneous tissue). The en-
tire procedure took 15–20 min and the attachments of the sensor
to the animal's back worked without complications. The monitor
was kept on the lid of the plastic cage that housed the rat after
surgery.
After connecting the transmitter with the monitor, a 2 h initializa-
tion period was required before starting the calibration of the RT-
CGMS.
The ﬁrst and second calibration procedures were performed 2 h
and 6 h after the installation of the RT-CGMs. Moreover, calibrations
were conﬁrmed every 12 h by measuring blood glucose levels with
a home glucometer (Diagnostics Accu-Chek® Active glucometer).
For this purpose, a blood droplet was obtained after a small incision
was made at the tip of the tail.
During the observation period, the surgery site for the insertion of
the sensor and transmitter did not show any sign of infection or
inﬂammation.
Finally, the sensor was removed and the data stored in the monitor
were transferred to a receptor (Con Link® Medtronic), which allowed
the study information to be downloaded to a personal computer con-
nected to an on line analysis program (CareLink personal® —
Medtronic).
Fig. 3 represents the kinetics for glucose changes in a pregnant rat
(day 20) during fed and fasted states. For comparative purposes, a
control NPWR (day 0) was submitted to the same experimental
procedure.
Fig. 4 represents the kinetics for glucose changes of a pregnant rat
(day 20) after an intraperitoneal injection of regular insulin (1 U/kg)
or oral (gavage) glucose administration (1 g/kg). The procedure for
insulin and glucose administration (starting 8:00 a.m.) were similar
to the previously described conventional ITT or GTT procedures.Fig. 2. Glycemic measurements 0, 10 and 60 min after oral (gavage) glucose administration
(14 days) and (D) pregnant rats (20 days). (a) pb0.05 — 0 min vs. 10 min; (b) pb0.05 — 1Moreover, a control NPWR (day 0) was submitted to the same exper-
imental procedure.
Liver perfusion experiments
The in situ liver perfusion technique was performed as previously
described (Nascimento et al., 2008). Gluconeogenesis from L-alanine
(5 mM), L-glutamine (5 mM) and glycerol (2 mM) in the livers of
PWR (day 20) and NPWR (day 0) which had fasted for 12 h, were
compared. As shown in Fig. 4, after a pre-infusion period (10 min)
the gluconeogenic substrate was infused during 70 min and submit-
ted to a post-infusion period (10 min without the gluconeogenic
substrate) in order to allow the glucose production values to return
to the levels of the pre-infusion period. Samples of the efﬂuent per-
fusion ﬂuid were collected every 5 min and the glucose concentra-
tion was measured (Bergmeyer and Bernt, 1974). The difference
between the glucose production during and before the infusion of
the liver glucose precursor represents the glucose production from
gluconeogenesis. The area under the curve (AUC) for the infusion pe-
riod of the gluconeogenic substrate was expressed as μmol/g.
In part of the liver perfusion experiments, the glycogen catabolism
in the fed state was measured. This experimental approach permitted
investigation of the basal rate of glycogenolysis and the activation of
glycogenolysis induced by epinephrine (Lopes et al., 1998). The dif-
ference between the glucose production during and before the infu-
sion of epinephrine was calculated by AUC analysis as previously
described.
Statistical analysis
The results are reported as mean±SEM. The data were evaluat-
ed by a Student t test and analysis of variance (one way and two
ways — ANOVAs) and the difference between means was assessed
by Tukey's test. A P value of less than 0.05 was considered
signiﬁcant.(1 g/kg). (A) Non-pregnant rats (0 day); (B) pregnant rats (7 days); (C) pregnant rats
0 min vs. 60 min. The data are reported as the mean±SEM of 7–9 animals per group.
Fig. 3. Kinetics of glucose concentration (mg/dL) on day 0 (●) and day 20 (■) of pregnancy (fed and fasted states). The time of food withdraw is represented by the dashed vertical
line. The data are reported as the mean±SEM of 5 measurements.
834 M.A. Carrara et al. / Life Sciences 90 (2012) 831–837Results
Blood glucose concentrations 0, 10 and 60 min after the insulin
injection are presented in Fig. 1. The percent decrease in glucose
levels after the insulin injection between 0 and 60 min was 70%
(Fig. 1A), 72% (Fig. 1B), 68% (Fig. 1C) and 55% (Fig. 1D) for the
NPWR (day 0), PWR (day 7), PWR (day 14) and PWR (day 21)
groups, respectively.
Fasting blood glucose levels 0, 10 and 60 min after the glucose ad-
ministration are presented in Fig. 2.
The percent increase in glucose levels after the glucose adminis-
tration between 0 and 10 min was 87% (Fig. 2A), 87% (Fig. 2B), 60%Fig. 4. Glucose levels (mg/dL) on day 0 (●) and 20 (■) of pregnancy after intraperitoneal
administration are represented by the dashed vertical line.(Fig. 2C) and 60% (Fig. 2D) for the NPWR (day 0), PWR (day 7),
PWR (day 14) and PWR (day 21) groups, respectively.
The kinetics of glucose changes and liver glucose production
(LGP) were measured 20 days after the start of pregnancy because
of the low percentage of glucose decrease after the insulin injec-
tion and the low percentage of glucose increase after the glucose
administration observed during this stage of pregnancy.
The kinetics of the glucose levels measurements according to
RT-CGMS showed negligible variations in the NPWR (day 0) fed
rats (i.e., an approximate mean of 106.7 mg/dL with glucose values
between 88 and 130 mg/dL). After fasting, the glucose values ﬂuc-
tuated at about a mean of 103.3 mg/dL with values between 90insulin (1 U/kg) (A) or oral (gavage) glucose (1 g/kg) administration (B). The time of
Fig. 6. Glycogenolysis during the infusion of epinephrine in fed rats on day 0 (●) and
day 20 (■) of pregnancy. The glucose concentration from the efﬂuent perfusate was
analyzed every 5 min. The data are reported as the mean±SEM of 3–6 experiments.
The comparison (area under curves) between day 0 and day 20 was not statistically
signiﬁcant (Pb0.05).
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states of the NPWR (day 0) were used here to deﬁne the basal
physiological condition in the absence of pregnancy. On the other
hand, PWR (day 20) showed a lower glucose concentration in
the fed and fasted states (PWR — day 20 vs. NPWR). Moreover,
after the initiation of fasting, PWR (day 20) showed a transitory
increase followed by a discrete decrease of glucose levels (Fig. 3).
The values of glucose levels as measured by RT-CGMS after insulin
(Fig. 4A) or glucose (Fig. 4B) administration showed less decrease and
less increase, respectively, in the fed PWR at day as compared with
PWR at day 0.
The results of gluconeogenesis and glycogenolysis from liver per-
fusion experiments are summarized in Figs. 5 and 6, respectively.
PWR (day 20 vs. day 0) exhibited a lower (pb0.05) LGP from L-ala-
nine (Fig. 5A) and L-glutamine (Fig. 5B), and a higher (pb0.05) LGP
from glycerol (Fig. 5C). On the other hand, as shown by Fig. 6, the
basal rates of glycogenolysis (before epinephrine infusion) and the
activation of glycogenolysis induced by epinephrine were similar
(day 20 vs. day 0).Fig. 5. Gluconeogenesis from L-alanine (A), L-glutamine (B) and glycerol (C) in per-
fused livers of 12 h fasted rats on day 0 (●) and day 20 (■) of pregnancy. The efﬂuent
perfusate was sampled at 5 min intervals and analyzed for glucose. The data are
reported as the mean±SEM of 3–6 experiments. All comparison (area under curves)
between days 0 and day 20 (to L-alanine, L-glutamine and glycerol) were statistically
signiﬁcant (Pb0.05).Discussion
Decreased insulin responsiveness of maternal tissues is a common
feature of late pregnancy and occurs in not only human (Hiramatsu et
al., 2000; Ehrlich et al., 2011; Schaefer-Graf et al., 2011) but also in
several species of mammalians, including rats (Leturque et al., 1986;
Ramos and Herrera, 1995; López-Luna et al., 1998). In agreement
with these studies, there was less of a decrease in glucose concentra-
tions after insulin injection in rats at 20 days of pregnancy when com-
pared with NPWR (Fig. 1). However, while insulin resistance in
human is associated with a high incidence of gestational diabetes,
this pathological change has not been observed in PWR, except
when animals have received a diabetogenic diet (Holemans et al.,
2004) or drugs (Reece et al., 2006; Campos et al., 2007; Saito et al.,
2010). In addition, PWR (day 20) also showed increased glucose tol-
erance when compared with NPWR (Fig. 2).
Because, insulin resistance (Fig. 1) and increased glucose toler-
ance (Fig. 2) were simultaneously observed on day 20 of pregnan-
cy, this day was chosen for the investigation of GTT, ITT, and the
glucose kinetics using the RT-CGMS technique. This technique per-
mits the identiﬁcation glucose trends with results in real time (Li
et al., 2010). However, RT-CGMS devices measure interstitial glu-
cose (Mastrototaro, 1999; Tiessen et al., 2002; Keenan et al.,
2009), and there is a physiologic lag time between the blood glu-
cose and the interstitial glucose levels of approximately 3 to
14 min (Rebrin et al., 1999; Steil et al., 2003). However, taken
into account our experimental conditions this lag time did not in-
ﬂuence the interpretation of our results.
In agreement with previous studies (Lü et al., 2010; Radermecker
and Scheen, 2010) we also demonstrated the feasibility of using cur-
rent sensor technology in order to achieve glucose monitoring in rats.
In other words, late pregnant rats had a lower (pb0.05) glucose con-
centration during fed and fasted states (Fig. 3).
Interestingly, between 12:00 and 20:00 there was a decrease
(pb0.05) of glucose levels among pregnant rats that reached 50 mg/
dL (Fig. 3). A possible explanation for these results is that rats are noc-
turnal animals, and between 12:00 and 20:00 there is a low frequency
of feeding. Consistent with these results, several reports conﬁrm that
during late pregnancy there is an increased predisposition to hypo-
glycemia in not only in rats (Leturque et al., 1989) but also human
(Vadakekut et al., 2011), mice (Reddi et al., 1976), ewes (Schlumbohm
and Harmeyer, 2008) and bitches (Johnson, 2008).
In addition, the simultaneous insulin resistance and increased glu-
cose tolerance demonstrated by conventional ITT (Fig. 1) and GTT
(Fig. 2) were conﬁrmed by RT-CGMS (Fig. 4).
The advantage of the CGMS technique is the fact that it allows re-
peated investigations of the same rat's insulin sensitivity and glucose
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cedures that can affect glucose levels. To our knowledge this study
represents the ﬁrst demonstration of the coexistence of insulin resis-
tance and increased glucose tolerance during late pregnancy using
the CGMS technique.
During late pregnancy, the presence of insulin resistance in muscle
(Barros et al., 2008; Camps et al., 1990) and adipose tissue (Wada
et al., 2010) is well established. However, the presence of insulin resis-
tance in liver during late pregnancy is controversial (Davidson, 1984;
Gilbert et al., 1991). Moreover, considering that abnormally elevated
glucose production is the main effect of insulin resistance in the liver,
the liver's glucose production from gluconeogenesis and glycogenolysis
were investigated.
In the speciﬁc case of gluconeogenesis, late pregnant rats exhib-
ited higher (pb0.05) glucose production from glycerol and lower
(pb0.05) glucose production from L-alanine and L-glutamine. Inter-
estingly, the former results are compatible with the general idea
that during late pregnancy the increased catabolism of lipids and
the intensiﬁcation of gluconeogenesis from glycerol could be a phys-
iological mechanism to protect against the loss of protein (Naismith
and Morgan, 1976). Furthermore, these results suggest that the
change in liver gluconeogenesis during late pregnancy is speciﬁc for
each gluconeogenic substrate and is consistent with the well-
established strategy of preferentially using of metabolites from lipol-
ysis during a period of reduced blood amino acids availability
(Herrera and Ortega-Senovilla, 2010). Moreover, the increased
sympatho-adrenal activity responsible for the accelerated mobiliza-
tion of fat deposits that occurs under both fed and fasting conditions
(Herrera et al., 1994) cannot be expanded by glucose production from
liver glycogen stores because the intensiﬁcation of hepatic glycogen-
olysis promoted by epinephrine was not different between PWR and
NPWR groups (Fig. 6).
Thus, the data shown in Figs. 5 and 6 suggest that the liver glucose
production was not affected by pregnancy.
The concomitant occurrence of insulin resistance and increased
glucose tolerance may appear paradoxical. However, these simulta-
neous changes should alter our view of insulin resistance in late preg-
nancy. The common association of insulin resistance with gestational
diabetes (Hod and Yogev, 2007) creates a paradigm that insulin resis-
tance is always a pathological process. In contrast with this idea our
results suggest that some degree of insulin resistance during preg-
nancy could be necessary for glucose maintenance during fasting.
On the other hand, the intense glucose utilization by the fetus,
which can be 50% of the maternal glucose utilization rate in the
basal state (Herrera et al., 1994) may help to explain the increased
glucose tolerance.
Thus, the following question can be raised: does the hypoglycemia
induced by fasting represent an insult to the fetus? In spite this ques-
tion is beyond the scope of previous studies that demonstrated in-
creased gluconeogenesis in the fetal liver during late-gestation
(Fowden et al., 1995; Franko et al., 2009; Thorn et al., 2009). There-
fore, the possibility of increased fetal liver glucose production com-
pensating for the lower availability of glucose from the mother
must be considered.
Conclusion
The coexistence of insulin resistance and increased glucose toler-
ance during late pregnancy may represent a very important physio-
logical mechanism that can guarantee the availability of glucose in
order to sustain the rapid fetal growth during the late gestation and
to prevent blood glucose decreases during fasting.
Finally, our results are of great clinical interest because they high-
light the difﬁculties establishing common reference values for the
glucose levels in the diagnosis of gestational diabetes. In our opinion,
the two following questions must be addressed before a consensuscan be reached. What should be considered a normal value of fasting
glucose levels during pregnancy? How can we distinguish physiolog-
ical and pathological insulin resistance during pregnancy? The an-
swers to these questions and establishing a better understanding of
the coexistence of insulin resistance and increased glucose tolerance
will be necessary before achieving a consensus regarding the values
of glucose levels for the diagnosis of gestational diabetes. In agree-
ment with this proposition, several studies have suggest a revaluation
of the normal values of fasting glucose levels and glucose tolerance
tests for the diagnosis of gestational diabetes. For example, the
World Health Organization criterion for the diagnosis of gestational
diabetes is a 2-h plasma glucose≥140 mg/dL with a 75-g oral glucose
tolerance test. However, increased birth weight and the risk of type 2
diabetes were observed with an increase of glucose levels above
120 mg/dL (Franks et al., 2006). Furthermore, the American Diabetes
Association position on the fasting value of glucose levels for the diag-
nosis of gestational diabetes has recently changed from ≥95 mg/dL
(ADA, 2010) to ≥92 mg/dL (ADA, 2011).
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